Search
Neurocrine Biosciences Inc
NBIXAdd to Watchlist
146.230USD
-5.600-3.69%
Close 09-18 16:00（ET）
14.85BMarket Cap
21.82P/E TTM
Neurocrine Biosciences Inc (NBIX) Revenue Performance
Updated: Jun 30, 2026Last year, Neurocrine Biosciences Inc generated 2.51B USD for its biggest-performing segment, INGREZZA. The United States made the largest contribution, accounting for 1.13B USD last year.
By Business
Revenue
Proportion
Annual
Annual
Quarterly
INGREZZA
CRENESSITY
Other
FY2025
FY2024
FY2023
INGREZZA
2.51B(88.70%)
2.31B(99.27%)
1.84B(98.68%)
CRENESSITY
301.20M(10.63%)
--(--)
--(--)
Other
19.00M(0.67%)
17.10M(0.73%)
24.60M(1.32%)
By Region
Revenue
Proportion
Annual
Annual
Quarterly
United States
FY2021
FY2020
FY2019
United States
1.13B(100.00%)
1.05B(100.00%)
788.09M(100.00%)